Jonathan S. Chávez-IñiguezMiguel Ibarra-EstradaEdgar Joel Carmona-MoralesAna Ron-MagañaRolando Claure-Del GranadoJuan Carlos VelezGael Chávez-AlonsoCarlos E. Orozco-ChanEstefania Villalvazo-MacielTania M. Anaya-Arce2026-03-222026-03-22202610.34067/kid.0000001136https://doi.org/10.34067/kid.0000001136https://andeanlibrary.org/handle/123456789/79497In patients with AKI and iron deficiency, a single dose of IV iron, compared to usual care, did not improve clinical outcomes evaluated by MAKE90, the hemoglobin value, but was safe.enMedicineAcute kidney injuryHemoglobinKidneyGastroenterologyIron deficiencyInternal medicineAcute kidney failureIron-deficiency anemiaKidney diseaseEffect of Intravenous Iron Dextran on Kidney Outcomes in Acute Kidney Injury with Iron Deficiencyarticle